Report Detail
Global Esketamine Hydrochloride Injection Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
- RnM4749464 |
- 05 October, 2026 |
- Global |
- 84 Pages |
- GIR |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Esketamine Hydrochloride Injection market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
Esketamine Injection is is an intravenous anesthetic, sold under the brand names Ketanest among others, is the S(+) enantiomer of ketamine. It is a dissociative hallucinogen drug used as a general anesthetic. Esketamine is the active enantiomer of ketamine in terms of NMDA receptor antagonism and is more potent than racemic ketamine.
This report is a detailed and comprehensive analysis for global Esketamine Hydrochloride Injection market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Specification and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Esketamine Hydrochloride Injection market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Esketamine Hydrochloride Injection market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Esketamine Hydrochloride Injection market size and forecasts, by Specification and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Esketamine Hydrochloride Injection market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Esketamine Hydrochloride Injection
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Esketamine Hydrochloride Injection market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Laboratoires CDM Lavoisier, Jiangsu Hengrui Medicine, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Esketamine Hydrochloride Injection market is split by Specification and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Specification, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Specification
2ml:50mg
5ml:25mg
Others
Market segment by Application
Hospitals and Clinics
Ambulatory Surgery Centers
Major players covered
Pfizer
Laboratoires CDM Lavoisier
Jiangsu Hengrui Medicine
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Esketamine Hydrochloride Injection product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Esketamine Hydrochloride Injection, with price, sales quantity, revenue, and global market share of Esketamine Hydrochloride Injection from 2021 to 2026.
Chapter 3, the Esketamine Hydrochloride Injection competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Esketamine Hydrochloride Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Specification and by Application, with sales market share and growth rate by Specification, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Esketamine Hydrochloride Injection market forecast, by regions, by Specification, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Esketamine Hydrochloride Injection.
Chapter 14 and 15, to describe Esketamine Hydrochloride Injection sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Specification
- 1.3.1 Overview: Global Esketamine Hydrochloride Injection Consumption Value by Specification: 2021 Versus 2025 Versus 2032
- 1.3.2 2ml:50mg
- 1.3.3 5ml:25mg
- 1.3.4 Others
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Esketamine Hydrochloride Injection Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 Hospitals and Clinics
- 1.4.3 Ambulatory Surgery Centers
- 1.5 Global Esketamine Hydrochloride Injection Market Size & Forecast
- 1.5.1 Global Esketamine Hydrochloride Injection Consumption Value (2021 & 2025 & 2032)
- 1.5.2 Global Esketamine Hydrochloride Injection Sales Quantity (2021-2032)
- 1.5.3 Global Esketamine Hydrochloride Injection Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 Pfizer
- 2.1.1 Pfizer Details
- 2.1.2 Pfizer Major Business
- 2.1.3 Pfizer Esketamine Hydrochloride Injection Product and Services
- 2.1.4 Pfizer Esketamine Hydrochloride Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Pfizer Recent Developments/Updates
- 2.2 Laboratoires CDM Lavoisier
- 2.2.1 Laboratoires CDM Lavoisier Details
- 2.2.2 Laboratoires CDM Lavoisier Major Business
- 2.2.3 Laboratoires CDM Lavoisier Esketamine Hydrochloride Injection Product and Services
- 2.2.4 Laboratoires CDM Lavoisier Esketamine Hydrochloride Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Laboratoires CDM Lavoisier Recent Developments/Updates
- 2.3 Jiangsu Hengrui Medicine
- 2.3.1 Jiangsu Hengrui Medicine Details
- 2.3.2 Jiangsu Hengrui Medicine Major Business
- 2.3.3 Jiangsu Hengrui Medicine Esketamine Hydrochloride Injection Product and Services
- 2.3.4 Jiangsu Hengrui Medicine Esketamine Hydrochloride Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 Jiangsu Hengrui Medicine Recent Developments/Updates
3 Competitive Environment: Esketamine Hydrochloride Injection by Manufacturer
- 3.1 Global Esketamine Hydrochloride Injection Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global Esketamine Hydrochloride Injection Revenue by Manufacturer (2021-2026)
- 3.3 Global Esketamine Hydrochloride Injection Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Esketamine Hydrochloride Injection by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Esketamine Hydrochloride Injection Manufacturer Market Share in 2025
- 3.4.3 Top 6 Esketamine Hydrochloride Injection Manufacturer Market Share in 2025
- 3.5 Esketamine Hydrochloride Injection Market: Overall Company Footprint Analysis
- 3.5.1 Esketamine Hydrochloride Injection Market: Region Footprint
- 3.5.2 Esketamine Hydrochloride Injection Market: Company Product Type Footprint
- 3.5.3 Esketamine Hydrochloride Injection Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Esketamine Hydrochloride Injection Market Size by Region
- 4.1.1 Global Esketamine Hydrochloride Injection Sales Quantity by Region (2021-2032)
- 4.1.2 Global Esketamine Hydrochloride Injection Consumption Value by Region (2021-2032)
- 4.1.3 Global Esketamine Hydrochloride Injection Average Price by Region (2021-2032)
- 4.2 North America Esketamine Hydrochloride Injection Consumption Value (2021-2032)
- 4.3 Europe Esketamine Hydrochloride Injection Consumption Value (2021-2032)
- 4.4 Asia-Pacific Esketamine Hydrochloride Injection Consumption Value (2021-2032)
- 4.5 South America Esketamine Hydrochloride Injection Consumption Value (2021-2032)
- 4.6 Middle East & Africa Esketamine Hydrochloride Injection Consumption Value (2021-2032)
5 Market Segment by Specification
- 5.1 Global Esketamine Hydrochloride Injection Sales Quantity by Specification (2021-2032)
- 5.2 Global Esketamine Hydrochloride Injection Consumption Value by Specification (2021-2032)
- 5.3 Global Esketamine Hydrochloride Injection Average Price by Specification (2021-2032)
6 Market Segment by Application
- 6.1 Global Esketamine Hydrochloride Injection Sales Quantity by Application (2021-2032)
- 6.2 Global Esketamine Hydrochloride Injection Consumption Value by Application (2021-2032)
- 6.3 Global Esketamine Hydrochloride Injection Average Price by Application (2021-2032)
7 North America
- 7.1 North America Esketamine Hydrochloride Injection Sales Quantity by Specification (2021-2032)
- 7.2 North America Esketamine Hydrochloride Injection Sales Quantity by Application (2021-2032)
- 7.3 North America Esketamine Hydrochloride Injection Market Size by Country
- 7.3.1 North America Esketamine Hydrochloride Injection Sales Quantity by Country (2021-2032)
- 7.3.2 North America Esketamine Hydrochloride Injection Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe Esketamine Hydrochloride Injection Sales Quantity by Specification (2021-2032)
- 8.2 Europe Esketamine Hydrochloride Injection Sales Quantity by Application (2021-2032)
- 8.3 Europe Esketamine Hydrochloride Injection Market Size by Country
- 8.3.1 Europe Esketamine Hydrochloride Injection Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Esketamine Hydrochloride Injection Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Esketamine Hydrochloride Injection Sales Quantity by Specification (2021-2032)
- 9.2 Asia-Pacific Esketamine Hydrochloride Injection Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific Esketamine Hydrochloride Injection Market Size by Region
- 9.3.1 Asia-Pacific Esketamine Hydrochloride Injection Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Esketamine Hydrochloride Injection Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America Esketamine Hydrochloride Injection Sales Quantity by Specification (2021-2032)
- 10.2 South America Esketamine Hydrochloride Injection Sales Quantity by Application (2021-2032)
- 10.3 South America Esketamine Hydrochloride Injection Market Size by Country
- 10.3.1 South America Esketamine Hydrochloride Injection Sales Quantity by Country (2021-2032)
- 10.3.2 South America Esketamine Hydrochloride Injection Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Esketamine Hydrochloride Injection Sales Quantity by Specification (2021-2032)
- 11.2 Middle East & Africa Esketamine Hydrochloride Injection Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa Esketamine Hydrochloride Injection Market Size by Country
- 11.3.1 Middle East & Africa Esketamine Hydrochloride Injection Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Esketamine Hydrochloride Injection Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 Esketamine Hydrochloride Injection Market Drivers
- 12.2 Esketamine Hydrochloride Injection Market Restraints
- 12.3 Esketamine Hydrochloride Injection Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Esketamine Hydrochloride Injection and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Esketamine Hydrochloride Injection
- 13.3 Esketamine Hydrochloride Injection Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Esketamine Hydrochloride Injection Typical Distributors
- 14.3 Esketamine Hydrochloride Injection Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Esketamine Hydrochloride Injection. Industry analysis & Market Report on Esketamine Hydrochloride Injection is a syndicated market report, published as Global Esketamine Hydrochloride Injection Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Esketamine Hydrochloride Injection market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
